Open science dataset drawn from cognitively healthy aging individuals with an increased risk of developing Alzheimer Disease.
The PREVENT-AD (Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease) cohort is composed of cognitively healthy participants over 55 years old, at risk of developing Alzheimer Disease (AD) as their parents and/or siblings were/are affected by the disease. These ‘at-risk’ participants have been followed for a naturalistic study of the presymptomatic phase of AD since 2011 using multimodal measurements of various disease indicators. Two clinical trials intended to test pharmaco-preventive agents have also been conducted. The PREVENT-AD research group is now releasing data openly with the intention to contribute to the community’s growing understanding of AD pathogenesis.
Additional details available in the PSC Bridges-2 Data Collections User Guide.
|Keywords||Alzheimers disease, clinical trials, statistics|
|Topics||Clinical Medicine; Statistics and Probability|
|Published By||The Douglas Research Centre Support|
|Supported By||XSEDE Help Desk (unavailable)|
|Hosted On||PSC Bridges-2 Regular Memory (Bridges-2 RM)|
|Provided By||Pittsburgh Supercomputing Center (PSC)|